Apply to trial NCT07817251

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 3Drug trial

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

The purpose of this clinical study is to look at the safety and tolerability of switching from semaglutide to CagriSema, for participants who have type 2 diabetes. All participants will get CagriSema, the treatment being tested. Participants will be in this clinical study for about 6 months.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening